The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis
Atherosclerotic cardiovascular disease (ASCVD) stands as the leading global cause of mortality. Addressing this vital and pervasive condition requires a multifaceted approach, in which antiplatelet intervention plays a pivotal role, together with antihypertensive, antidiabetic, and lipid-lowering th...
Main Authors: | Minji Sohn, Soo Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/5/2593 |
Similar Items
-
Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
by: Sangmo Hong, et al.
Published: (2022-04-01) -
DESCRIPTION OF EFFECTIVENESS OF CILOSTAZOL AND ASPIRIN AS ADJUVANT OF DIABETIC FOOT WAGNER GRADE II AND III
by: Pandji Winata Nurikhwan, et al.
Published: (2014-09-01) -
DESCRIPTION OF EFFECTIVENESS OF CILOSTAZOL AND ASPIRIN AS ADJUVANT OF DIABETIC FOOT WAGNER GRADE II AND III
by: Pandji Winata Nurikhwan, et al.
Published: (2014-09-01) -
THE FEATURES OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC CORONARY SYNDROME ON THE BACKGROUND OF GENERALIZED ATHEROSCLEROSIS UNDER THE INFLUECE OF CILOSTAZOL
by: Tatiana Motsak
Published: (2020-11-01) -
Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
by: Shinichiro Uchiyama, et al.
Published: (2015-01-01)